BackJiangsu Bioperfectus Technologies , Ltd. Overview

Jiangsu Bioperfectus Technologies , Ltd. Inventory

Track Jiangsu Bioperfectus Technologies , Ltd.'s inventory ($47M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$47.09M
↓ 10.72% YoYΔ $-5.65M vs prior year quarter

Peer trimmed avg / median

Loading

Jiangsu Bioperfectus Technologies , Ltd. Inventory History

Loading

Jiangsu Bioperfectus Technologies , Ltd. vs. peers: Inventory Comparison

Loading

Jiangsu Bioperfectus Technologies , Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jiangsu Bioperfectus Technologies , Ltd. (688399.SS) FAQ

Jiangsu Bioperfectus Technologies , Ltd. posts a inventory of $47M as of June 2026. That compares with $53M in the prior-year period — down 10.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Jiangsu Bioperfectus Technologies , Ltd.'s inventory was $53M. The latest reading is $47M — a 10.7% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of Jiangsu Bioperfectus Technologies , Ltd.'s financial statement story. At $47M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 688399.SS's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Jiangsu Bioperfectus Technologies , Ltd.'s other metric pages and overview cover the third.

Judging Jiangsu Bioperfectus Technologies , Ltd. against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in inventory easier to interpret. Start with $47M here, then scan peer and history charts to see if the gap is persistent.